View
2
Download
0
Category
Preview:
Citation preview
Manufactured into plasma-derived therapies
Rare Disease Patients
Single DonorTransfusion
Manufactured into Hyperimmune Ig
(Pooled from many donors,processed & standardized)
SOURCE PLASMACOVID-19 CONVALESCENT PLASMA (CCP)
PLASMA TREATMENTS:IMPORTANT DISTINCTIONS
BLOOD CLOTTING FACTORS: Hemophilia, Von Willebrand disease
ALPHA-1 PROTEINASE INHIBITOR: Alpha-1 antitrypsin deficiency
ALBUMIN: Certain liver conditions, Burns, Shock, Trauma
IMMUNOGLOBULIN (IG): Primary Immunodeficiency diseases, GBS/CIDP, Kawasaki disease, Secondary antibody deficiencies (Cancer), MIS-C, COVID-19
C1 ESTERASE INHIBITOR (C1-INH): Hereditary Angioedema
High RiskIndividuals
COVID-19Patients
AUGU
ST 2
020
#PlasmaDonorsSaveLivesFOR MORE INFORMATION AND WAYS TO DONATE, VISIT:
WWW.DONATINGPLASMA.ORG
Recommended